Professor Kim Do-kyung from Kyung Hee University's College of Medicine has been selected for the second phase of the 'IP Star Scientist' project, organized by the Ministry of Science and ICT. This project aims to support the commercialization of knowledge property-based technologies in the medical field. Following the successful completion of Phase 1 from 2024 to 2025, his research team will now manage a total budget of 850 million KRW over the next two years. This funding includes 400 million KRW from the government and an additional 50 million KRW from Daewoong Pharmaceutical to further develop promising cancer treatment technologies.

During Phase 1, his team focused on enhancing photodynamic therapy (PDT) for skin cancer treatment, which selectively destroys cancer cells using photosensitizers activated by light. Traditional materials faced challenges with low solubility and toxicity, but the team successfully developed two novel photosensitizer materials: Nitrobenzo-Selenadiazole-metal complex (NCCN) and Terephthalate-Cyclohexylamine polymer (PANA). These materials showcase significant improvements in production efficiency and therapeutic efficacy, thereby representing a potential breakthrough in cancer treatment techniques.